Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Pharmacol Res. 2016 Jul;109:4-11. doi: 10.1016/j.phrs.2016.01.014. Epub 2016 Jan 24.

Argentinean Society of Experimental Pharmacology: Brief history and main scientific contributions to the discipline.

Author information

1
Full Professor of Pharmacology, Current President of the Argentinean Society of Experimental Pharmacology, Laboratory of Pharmacology, Faculty of Veterinary Medicine, Universidad Nacional del Centro de la Provincia de Buenos Aires, B7001BBO Tandil, Argentina. Electronic address: sbruni@vet.unicen.edu.ar.
2
Current 2° Vocal of the Argentinean Society of Experimental Pharmacology. Instituto de Investigaciones Farmacológicas (ININFA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires (UBA), Junín 956, 5to piso, C1113AAD, Ciudad Autónoma de Buenos Aires, Argentina.

Abstract

Argentina Biomedical Science has been historically strong. The development of Human and Veterinary Pharmacology in our country as a pivotal discipline has been acknowledged worldwide because of the quality of its contributions. Argentinean Society of Experimental Pharmacology (SAFE) is a non- profit association whose research fields include Experimental and Clinical Pharmacology. SAFE main goals are described as follow (a) To meet active researchers for studying concerns regarding Experimental and Clinical Pharmacology (b) To launch an initiative for development of the discipline in mainly our country and other collaborative countries worldwide (c) To spread the pharmacological know-how obtained from different research teams (d) To strengthen relations between pharmacologists (e) To facilitate the presentation and discussion of scientific papers. This current article shows the SAFE's more important scientific contribution to pharmacology through its former research scientists to the present.

KEYWORDS:

Alfusozine, a peripherally acting alpha-1 adrenoceptor antagonist; Development; Diltiazem, a calcium antagonist; Glutaprodil, a noncompetitive antagonist of the iononotropic NMDA receptor; Mizolastine, a peripherally acting histamine H-1 receptor antagonist; Pharmacologists; SAFE; Scientific contribution; Xatral; Zolpidem, a selective full agonist of the alpha-1 subunit of the benzodiazepine-GABA-A receptor

PMID:
26816088
DOI:
10.1016/j.phrs.2016.01.014
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center